India News | Approval to Covaxin for Children Aged Between 2-18 Years Awaited After Evaluation of Data
Get latest articles and stories on India at LatestLY. After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Bharat Biotech, the manufacturer of Covaxin, has submitted data for clinical trials in the age group of 2-18 years to Central Drugs Standard Control Organisation (CDSCO).
Also Read | Real Estate Giants Say Commercial Property Demand Witnesses Increase During Navratri, Festive Season.
The data has been thoroughly reviewed by the CDSCO and Subject Experts Committee and has provided their positive recommendations. (ANI)
(The above story is verified and authored by ANI staff, ANI is South Asia's leading multimedia news agency with over 100 bureaus in India, South Asia and across the globe. ANI brings the latest news on Politics and Current Affairs in India & around the World, Sports, Health, Fitness, Entertainment, & News. The views appearing in the above post do not reflect the opinions of LatestLY)